Oklahoma Teens Participate In Clinical Trial For COVID-19 Vaccines

Although the COVID-19 vaccine is becoming more widely available for adults, those under 18 don't have the green light just yet. That is why clinical trials are being held across the country including in Oklahoma City.

Friday, February 26th 2021, 5:22 pm



-

Although the COVID-19 vaccine is becoming more widely available for adults, those under 18 don't have the green light just yet. That is why clinical trials are being held across the country including in Oklahoma City.

Two brothers in the metro have decided they wanted to participate in the trial.

“We first heard about it from my son’s pediatrician,” said Faizah Bhatti, the boys' mom who is also a doctor and researcher.

Bhatti said her sons were open to the idea and jumped at the opportunity to do it. This was after they watched their mom beat the virus and get the vaccine.

“She was tired and couldn’t get out of bed for days,” said Daniyal Khan, who is participating in the trial.

Both teens have been given their first shot, but they don’t know if they received the vaccine or the placebo.

“I didn’t have a sore arm like my brother had,” said Ayaan Khan, who is also a part of the trial.

On Friday, the boys returned to the Lynn Institute in Oklahoma City, where the trial is being conducted, for their second shot. Both said they have chosen to believe in the science and trust in their mom to help make this vaccine available for others their age.

“It is better to be safe than sorry,” said Daniyal.

The trial is a year long. When it is over, the participants will learn if they received the vaccine or the placebo. If they got the placebo, they will be able to get the vaccine.

logo

Get The Daily Update!

Be among the first to get breaking news, weather, and general news updates from News 9 delivered right to your inbox!

More Like This

February 26th, 2021

March 7th, 2022

March 7th, 2022

February 19th, 2022

Top Headlines

March 29th, 2024

March 29th, 2024

March 29th, 2024

March 29th, 2024